Current:Home > InvestCDC recommends new booster shots to fight omicron -Quantum Capital Pro
CDC recommends new booster shots to fight omicron
View
Date:2025-04-17 16:47:23
The Centers for Disease Control and Prevention has endorsed the first updated COVID-19 booster shots.
The decision came just hours after advisers to the CDC voted to recommend reformulated versions of the Moderna and Pfizer-BioNTech COVID-19 vaccines. The vote was 13 in favor and one no vote.
"The updated COVID-19 boosters are formulated to better protect against the most recently circulating COVID-19 variant," Walensky said in a written statement announcing the recommendation.
"If you are eligible, there is no bad time to get your COVID-19 booster and I strongly encourage you to receive it," Walensky said.
The booster shots target both the original strain of the coronavirus and the omicron BA.4 and BA.5 subvariants that most people are catching now. This double-barreled vaccine is called a bivalent vaccine.
The CDC advisers recommended that anyone age 12 and older get the new Pfizer-BioNTech boosters as authorized by the Food and Drug Administration. The updated Moderna COVID-19 vaccine is authorized for anyone 18 and older.
In both cases people would have to wait two months after completing their initial vaccination or their last booster shot. But many vaccine experts say it would be better to wait at least four months since the last shot or COVID infection, or the boosters won't work as well.
This is the first time the FDA has authorized COVID vaccines without requiring they get tested in people. To keep up with the rapidly evolving virus, the FDA relied on how well the shots stimulated the immune systems of mice. They also looked at how well similar shots targeted at earlier variants worked on people.
The companies and federal officials say there's no question the shots are safe and they argue the evidence indicates the reformulated boosters will help reduce the chances people will catch the virus and spread it.
But some people wonder if it would be better to wait for the results from human studies that are already underway.
"It certainly looks very promising," said CDC advisor Dr. Pablo Sanchez from The Ohio State University at Thursday's hearing. "I understand the constant shift of these variants but studies with the BA.4 and BA.5 are ongoing in humans and I just wonder if it's a little premature," he said. Sanchez was the only adviser to vote no. "I voted no because I feel we really need the human data," he explained. "There's a lot of vaccine hesitancy already. We need human data."
But other advisers were more comfortable, pointing out that flu vaccines are updated every year without being tested in people.
"This is the future that we're heading for," says Dr. Jamie Loehr of Cayuga Family Medicine. "We're going to have more variants and we should be treating this like the flu, where we can use new strain variants every year." Loehr says he's comfortable recommending the updated boosters, "even if we don't have human data."
Committee chair, Dr. Grace Lee, professor of pediatric infectious diseases at Stanford Medicine recognized there is some uncertainty, "I want to acknowledge it," she said. "And I just want to say that despite that I think we hopefully made a huge impact in our ability to weather this pandemic together."
Between 400 and 500 people are still dying every day in the U.S. from COVID-19 and public health officials are worried another surge could hit this fall or winter. The administration hopes the reformulated boosters will help contain a surge and protect people from serious disease or death.
The federal government plans to make the boosters available quickly. In advance of the FDA's decision, Dr. Ashish Jha, the White House COVID-19 response coordinator told NPR that the new boosters represented "a really important moment in this pandemic."
Now the CDC has signed off, few shots could be available as early as Friday, with a wider rollout next week.
veryGood! (48868)
Related
- 'Kraven the Hunter' spoilers! Let's dig into that twisty ending, supervillain reveal
- The Prime Show: All bling, no bang once again as Colorado struggles past North Dakota State
- Tallulah Willis Shares Insight Into Her Mental Health Journey Amid New Venture
- Neighbor held in disappearance of couple from California nudist resort. Both believed to be dead
- A South Texas lawmaker’s 15
- Jewish students at Columbia faced hostile environment during pro-Palestinian protests, report finds
- Lionel Messi's Inter Miami already in MLS playoffs. Which teams are in contention?
- A fifth of Red Lobsters are gone. Here's every US location that's still open
- Are Instagram, Facebook and WhatsApp down? Meta says most issues resolved after outages
- Federal Reserve’s favored inflation gauge shows price pressures easing as rate cuts near
Ranking
- Paula Abdul settles lawsuit with former 'So You Think You Can Dance' co
- Alexei Popyrin knocks out defending champ Novak Djokovic in US Open third round
- Contract security officers leave jail in Atlanta after nonpayment of contract
- Court stops Pennsylvania counties from throwing out mail-in votes over incorrect envelope dates
- North Carolina trustees approve Bill Belichick’s deal ahead of introductory news conference
- Runners are used to toughing it out. A warming climate can make that deadly
- Oklahoma rodeo company blames tainted feed for killing as many as 70 horses
- Where Summer House's Lindsay Hubbard & Carl Radke Stand One Year After Breakup
Recommendation
Juan Soto praise of Mets' future a tough sight for Yankees, but World Series goal remains
Child abuse images removed from AI image-generator training source, researchers say
While not as popular as dogs, ferrets are the 'clowns of the clinic,' vet says
As Mike McCarthy enters make-or-break year, unprecedented scrutiny awaits Cowboys coach
Sarah J. Maas books explained: How to read 'ACOTAR,' 'Throne of Glass' in order.
Tom Hanks Warns Fans Not to Be Swindled by Wonder Drug Scheme Using His Image
Stock market today: Wall Street rises as inflation report confirms price increases are cooling
Lululemon Labor Day Finds: Snag $118 Align Leggings for Only $59, Tops for $39, & More Styles Under $99